LOS ANGELES, CA — Treat-to-target protocols for patients with moderate-to-severe
Read moreHome »
A personalized genomic cancer vaccine proved feasible to manufacture and
Read moreNEW YORK (Reuters Health) – In more than one of
Read moreNEW YORK (Reuters Health) – Bevacizumab improved visual acuity and
Read moreNEW YORK (Reuters Health) – Bevacizumab improved visual acuity and
Read moreMore adolescent girls than boys experienced nonfatal opioid overdose and
Read moreMOSCOW (Reuters) – Nearly two thirds of Russians are not
Read moreResearchers studying a large set of small cell lung cancer
Read moreThe rate of hospital admissions in the United Kingdom for
Read more